絞り込み

17791

広告

「"Brown JP "[Author]」の検索結果

528件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis?

James Meyrick Croker: A Model for Professional Behavior.

A scorecard for osteoporosis in Canada and seven Canadian provinces.

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.

Adaptations and modifications in the technique of laparoscopic hysterectomy with bilateral adnexectomy in the time of COVID-19.

Defining Major Depressive Disorder Cohorts Using the EHR: Multiple Phenotypes Based on ICD-9 Codes and Medication Orders.

Public Dental Services, Queensland, Australia: Charles Octavius Vidgen.

Public Dental Services, Queensland: Alan Thomas Robertson.

Mental Health Consequences of Shift Work: An Updated Review.

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.

Self-reported sleep duration is associated with time in work physical activity but not transportation or leisure physical activity among Hispanic/Latino adults in the U.S.: results from the Hispanic Community Health Study/Study of Latinos.

Change in Quantitative Ultrasound-assessed Speed of Sound as a Function of Age in Women and Men and Association With the Use of Antiresorptive Agents: The Canadian Multicentre Osteoporosis Study.

Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013-2017.

Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression.

Special Report From the Society for the Advancement of Blood Management: The Choosing Wisely Campaign.

Adapting systems thinking and safety reporting in high-consequence industries to healthcare.

Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment.

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos).

Relationship Between Bone Mineral Density T-score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります